A proud and remarkable moment for Bangladesh’s healthcare and pharmaceutical research sector

C2C Pharma Ltd. believes in quality and it’s not just word of mouth, we have proven it in our daily practice. Bangladesh Council of Scientific and Industrial Research (BCSIR) officially signed an agreement with ICDDR,B, and C2C Pharma Ltd. & other renowned pharmaceutical companies with the aim of making analysis, method development, quality control, testing services and clinical research activities. In the presence of Md Anwar Hossain, Ministry of  Science and Technology secretary, the BCSIR signed the agreements with C2C Pharma Ltd. We are grateful & would like to express special thanks to the Chairman, Dr. Samina Ahmed, the Director Dr. Md. Hossain Sohrab, and the entire team of BCSIR.

Mr. Anis Uz Zaman, the Director & CEO, Md. Rasel Uddin Shah, Head of Quality Operations and Mohammed Raihan Chowdhury, Head of Quality Assurance have signed the agreement on behalf of C2C Pharma. Highlighting the issue, a press release is published in different daily Newspapers.

We believe that this partnership will pave the way for impactful research, quality healthcare advancement, and global opportunities in the pharmaceutical sector.

News Link: https://lnkd.in/gd7vKsEU

Prev post

Leave A Reply